Brewin Dolphin LTD Amgen Inc Transaction History

Brewin Dolphin LTD

$2.08 Billion
Q2 2022

A detailed history of Brewin Dolphin LTD transactions in Amgen Inc stock. As of the latest transaction made, Brewin Dolphin LTD holds 1,077 shares of AMGN stock, worth $317,208. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,077

Previous 1,077 -0.0%

Holding current value

$317,208

Previous $260,000 0.77%

% of portfolio

0.01%

Previous 0.01%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Nov 14, 2022	BUY	$198.88 - $227.6 $214,193 - $245,125	1,077 New	1,077 $242,000
Q3 2021 Nov 09, 2023	SELL	$212.27 - $248.7 $14,858 - $17,409	-70 Reduced 6.54%	1,001 $213 Million
Q2 2021 Nov 09, 2023	SELL	$233.58 - $259.14 $6,306 - $6,996	-27 Reduced 2.46%	1,071 $261 Million
Q1 2021 Nov 09, 2023	SELL	$221.91 - $258.6 $25,519 - $29,739	-115 Reduced 9.48%	1,098 $273 Million
Q4 2020 Nov 09, 2023	BUY	$216.38 - $257.67 $69,025 - $82,196	319 Added 35.68%	1,213 $279 Million
Q3 2020 Nov 09, 2023	BUY	$234.65 - $260.95 $26,984 - $30,009	115 Added 14.76%	894 $227 Million
Q2 2020 Nov 09, 2023	BUY	$197.81 - $242.74 $55,584 - $68,209	281 Added 56.43%	779 $184 Million
Q3 2019 Nov 09, 2023	SELL	$174.11 - $208.62 $34,473 - $41,306	-198 Reduced 28.45%	498 $96.4 Million
Q1 2019 Nov 09, 2023	BUY	$180.87 - $203.88 $53,356 - $60,144	295 Added 73.57%	696 $132 Million
Q3 2018 Nov 09, 2023	SELL	$185.29 - $208.89 $16,861 - $19,008	-91 Reduced 18.5%	401 $83.1 Million
Q2 2018 Nov 09, 2023	SELL	$166.05 - $186.51 $16,605 - $18,651	-100 Reduced 16.89%	492 $90.8 Million
Q1 2018 Nov 09, 2023	SELL	$169.43 - $198.0 $83,867 - $98,010	-495 Reduced 45.54%	592 $101 Million
Q3 2017 Nov 09, 2023	BUY	$167.29 - $191.0 $1,672 - $1,910	10	1,087 $203 Million

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Brewin Dolphin LTD, based on Form 13F filings with the SEC.

News

Stay updated on Brewin Dolphin LTD with notifications on news.

Account

Brewin Dolphin LTD Amgen Inc Transaction History